JCES 01.27 Patients with ALK IHC-Positive/FISH-Negative NSCLC Benefit from ALK TKI Treatment: Response Data from the Global ALEX Trial T. Mok, S. Peters,D. Ross Camidge, S. Gadgeel, S.I. Ou,D. Kim, R. Dziadziuszko,F. De Marinis, R. Sangha, A. Zeaiter, J. Noe, E. Nueesch,T. Liu, I. Loftin, C. Williams, A. ShawJournal of Thoracic Oncology（2017）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
